My Impression is that BMS somewhat validated the price of Nektar in the $100 range. With that in mind and seeing that Nektar is well capitalized I can put a couple of my concerns on the back burner.
Keep in mind there are other drugs in progress as well.
As far as the macro investment picture unveils itself it might be time to hide in something safe.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.